Filgrastim biosimilar (Zuventus Healthcare)

非格司亭生物类似药（Zuventus Healthcare）

Report date: 2022/02/17 13:36:38

Base Information

Drug NameFilgrastim biosimilar (Zuventus Healthcare)

Drug Alias NameRecombinant human granulocyte macrophage colony stimulating factor (Zuventus Healthcare)非格司亭生物仿制药（Zuventus Healthcare）rhG-CSF (Zuventus Healthcare)重组人粒细胞刺激因子（Zuventus Healthcare）

ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Biosimilar

Mechanisms of ActionColony stimulating factor 3 receptor agonists

TargetsColony stimulating factor 3 receptor

Therapy Area/IndicationsNeutropenia

Global Approved IndicationsNeutropenia

Approved Indications in ChinaN/A

Original Approved Country/TerritoryIndia

Original Approved Date2012/08/01

Country/TerritoryIndia

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesZuventus Healthcare

China Registration ClassN/A

Develop Information

Active CompaniesZuventus Healthcare

Inactive CompaniesN/A

Active IndicationsNeutropenia

Inactive IndicationsN/A

Other Information

ATC CodeL03AA02